The use of inhaled mannitol for assessing airway disease

Symposium
Chairs: G. Joos (Gent, Belgium), I. Steenbruggen (Zwolle, The Netherlands)
Aims: The aims of this symposium will be:
• to discuss the effect of various bronchial provocation tests on people with asthma;
• to identify the advantages and limitations of inhaled mannitol in children and adults;
• to discuss implications for everyday practice.

Direct versus indirect airway challenges G. Joos (Gent, Belgium)
Inhaled mannitol as treatment for children with cystic fibrosis A. Bush (London, United Kingdom)
Implications for everyday practice R. Rodríguez-Roisin (Barcelona, Spain)